Table 5 Change in disease activity – DAS28 score over the study period
From: Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines
Low-Moderate | High disease | Remission | Total (n) | |
|---|---|---|---|---|
Baseline | 12 (70.6) | 3 (17.6) | 1 (11.8) | 17 |
3 Weeks | 11 (64.7) | 1 (5.9) | 5 (29.4) | 17 |
6 Weeks | 11 (64.7) | 2 (11.8) | 4 (23.5) | 17 |
3 Months | 11 (68.8) | 1 (6.3) | 4 (25.0) | 16 |
6 Months | 12 (75.0) | 0 (0.0) | 4 (25.0) | 16 |
12 Months | 13 (81.3) | 0 (0) | 3 (18.8) | 16 |